Inventiva (IVA) Common Equity (2018 - 2025)
Inventiva's (IVA) quarterly Common Equity came in at -$33.2 million in Q4 2025, up 70.87% year-on-year from -$19.4 million in Q4 2024, and up 99.67% quarter-over-quarter from -$10.1 billion in Q2 2025.
Inventiva (IVA) Common Equity (2018 - 2025) Analysis & Trends
Inventiva's Common Equity history runs 8 years deep, the most recent figure standing at -$33.2 million for Q4 2025.
- On a quarterly basis, Common Equity rose 70.87% year-over-year to -$33.2 million in Q4 2025; TTM through Dec 2025 was -$33.2 million, a 70.87% increase from a year earlier, with the FY2025 full-year figure at -$33.2 million, up 70.87% from the prior year.
- Common Equity advanced to -$33.2 million in Q4 2025 per IVA's latest filing, from -$10.1 billion in the prior quarter.
- Across five years, Common Equity topped out at $217.4 billion in Q2 2024 and bottomed at -$10.1 billion in Q2 2025.
- The 5-year median for Common Equity is $74.0 million (2021), against an average of $39.3 billion.
- Across the five-year window, Common Equity surged 69694.74% in 2022 and sank 230.67% in 2024, its largest moves.
- Year by year, Common Equity stood at $101.7 million in 2021, then tumbled by 54.36% to $46.4 million in 2022, then plunged by 174.28% to -$34.5 million in 2023, then slumped by 230.67% to -$114.0 million in 2024, then jumped by 70.87% to -$33.2 million in 2025.
- Per Business Quant, the three latest IVA Common Equity figures stand at -$33.2 million (Q4 2025), -$10.1 billion (Q2 2025), and -$114.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | -33.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.20 Mn |
| Jun 30, 2025 | -10.08 Bn |
| Dec 31, 2024 | -113.96 Mn |
| Jun 30, 2024 | 217.38 Bn |
| Dec 31, 2023 | -34.46 Mn |
| Oct 11, 2023 | 24.55 Mn |
| Jun 30, 2023 | 189.35 Bn |
| Dec 31, 2022 | 46.40 Mn |
| Jun 30, 2022 | 74.40 Bn |
| Dec 31, 2021 | 101.66 Mn |
| Jun 30, 2021 | 106.60 Mn |
| Mar 31, 2021 | 123.34 Mn |
| Dec 31, 2020 | 132.60 Mn |
| Jun 30, 2020 | 45.97 Mn |
| Dec 31, 2019 | 45.82 Mn |
| Dec 31, 2018 | 70.31 Mn |